🔎 Trials Near Me

Avaleht › Kopsuvähk › Iowa

Kopsuvähk kliinilised uuringud osariigis Iowa

19 uuringut haiguse Kopsuvähk jaoks otsivad osalejaid osariigis Iowa.

Linnad osariigis Iowa

Ametlik uuringutekst (inglise keeles)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • ja veel 14
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • ja veel 12
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • ja veel 7
VärbamineFaas 3
Vanused 70 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • ja veel 10
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • ja veel 11
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • University of Iowa Health Care Cancer Services Quad Cities, Bettendorf
  • University of Iowa Hospitals & Clinics, Iowa City
  • University of Iowa Health Care, Mission Cancer + Blood, Waukee
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT06881784

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Local Institution - 0065, Iowa City
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Physicians Clinic of Iowa, Cedar Rapids
  • Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT06712316

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • McFarland Clinic, Ames
  • Helen G. Nassif Community Cancer Center, Cedar Rapids
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • ja veel 12
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT05624996

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 19–110 · Kõik sood · Uuendatud 29. juuni 2026 · NCT02012699

CHAMP Lung Cancer Screening Program

  • University of Iowa, Iowa City
  • Cedar Valley Primary Care & Walk-In Clinic, Waterloo
  • Greenwood Pharmacy and Compounding Center, Waterloo
Värbamine
Vanused 50–77 · Kõik sood · Uuendatud 16. juuni 2026 · NCT07572773

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive
  • Iowa Methodist Medical Center, Des Moines
  • ja veel 4
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. juuni 2026 · NCT05642572

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  • University of Iowa Health Care, Iowa City
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. mai 2026 · NCT06922591

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • ja veel 7
VärbamineFaas 2
18 Minutes · Kõik sood · Uuendatud 5. mai 2026 · NCT06031688

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

  • University of Iowa Hospitals and Clinics, Iowa City
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. apr 2026 · NCT04919382

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

  • University of Iowa, Iowa City
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 2. jaan 2026 · NCT06925295

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 28. okt 2025 · NCT03452774

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.